Abstract
Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitus1,2,3. The molecular basis of this common syndrome, however, is poorly understood. It has been suggested that tumour necrosis factor (TNF)-α is a candidate mediator of insulin resistance in obesity, as it is overexpressed in the adipose tissues of rodents and humans4,5,6,7,8,9,10 and it blocks the action of insulin in cultured cells and whole animals10,11,12,13,14. To investigate the role of TNF-α in obesity and insulin resistance, we have generated obese mice with a targeted null mutation in the gene encoding TNF-α and those encoding the two receptors for TNF-α. The absence of TNF-α resulted in significantly improved insulin sensitivity in both diet-induced obesity and that resulting for the ob/ob model of obesity. The TNFα-deficient obese mice had lower levels of circulating free fatty acids, and were protected from the obesity-related reduction in the insulin receptor signalling in muscle and fat tissues. These results indicate that TNF-α is an important mediator of insulin resistance in obesity through its effects on several important sites of insulin action.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45, 3–10 (1997).
Carey, V. J. et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women – the nurses health study. Am. J. Epidemiol. 145, 614–619 (1997).
Edelstein, S. L. et al. Predictors of progression from impaired glucose tolerance to NIDDM. Diabetes 46, 701–710 (1997).
Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993).
Hofmann, C. et al. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134, 264–270 (1994).
Hamann, A. et al. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44, 1266–1273 (1995).
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. & Spiegelman, B. M. Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409–2415 (1995).
Kern, P. A. et al. The expresison of tumor necrosis factor in adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111–2119 (1995).
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R. & Kern, P. A. The expression of TNFα by human muscle: relationship to insulin resistance. J. Clin. Invest. 97, 1111–1116 (1996).
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. & Spiegelman, B. M. Differential regulation of the p80 TNF receptor in human obesity and insulin resistance. Diabetes 46, 451–455 (1997).
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B. & Karasik, A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268, 26055–26058 (1993).
Hotamisligil, G. S., Murray, D. L., Choy, L. N. & Spiegelman, B. M. TNF-α inhibits signaling from insulin receptor. Proc. Natl Acad. Sci. USA 91, 4854–4858 (1994).
Kanety, H., Feinstein, R., Papa, M. Z., Hemi, R. & Karasik, A. Tumor necrosis factor-α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). J. Biol. Chem. 270, 23780–23784 (1995).
Kroder, G. et al. Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J. Clin. Invest. 97, 1471–1477 (1996).
Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271, 665–668 (1996).
Stephens, J. M. & Pekala, P. H. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 266, 21839–21845 (1991).
Stephens, J. M., Lee, J. L. & Pilch, P. F. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and glut4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272, 971–976 (1997).
Marino, M. W. et al. Characterization of tumor necrosis factor deficient mice. Proc. Natl Acad. Sci. USA 94, 8093–8098 (1997).
Bruce, A. J. et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2, 788–794 (1996).
Coleman, D. L. in The Mouse in Biomedical Research (ed. Foster, M.) 125–132 (Academic, London, (1982)).
Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121–153 (Elsevier, New York, (1990)).
Cornelius, P., Lee, M. D., Marlowe, M. & Pekala, P. H. Monokine regulation of glucose transporter mRNA in L6 myotubes. Biochem. Biophys. Res. Commun. 165, 429–436 (1989).
Hotamisligil, G. S., Budavari, A., Murray, D. L. & Spiegelman, B. M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J. Clin. Invest. 94, 1543–1549 (1994).
White, M. F. & Kahn, C. R. The insulin signaling system. J. Biol. Chem. 269, 1–4 (1994).
Fiedorek, F. T. in Diabetes Mellitus: a Fundamental and Clinical Text (eds LeRoith, D., Taylor, S. I. & Olefsky, J. M.) 604–618 (Lippincott-Raven, Philadelphia, (1996)).
Hotamisligil, G. S. et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274, 1377–1379 (1996).
Acknowledgements
We thank J. Perschon for generation of the TNF receptor-deficient mice, and members of the Hotamisligil laboratory for discussions and support. This work is in part supported by grants from the NIH and American Diabetes Foundation (G.S.H.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uysal, K., Wiesbrock, S., Marino, M. et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610–614 (1997). https://doi.org/10.1038/39335
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/39335
This article is cited by
-
Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease
Cardiovascular Diabetology (2024)
-
White adipocyte dysfunction and obesity-associated pathologies in humans
Nature Reviews Molecular Cell Biology (2024)
-
Phage cocktail alleviated type 2 diabetes by reshaping gut microbiota and decreasing proinflammatory cytokines
Applied Microbiology and Biotechnology (2024)
-
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The Egyptian Heart Journal (2023)
-
MSR1 is not required for obesity-associated inflammation and insulin resistance in mice
Scientific Reports (2023)